<DOC>
	<DOCNO>NCT00882765</DOCNO>
	<brief_summary>RATIONALE : Genistein may stop growth tumor cell block enzymes need cell growth block blood flow tumor . Giving genistein surgery may effective treatment pancreatic cancer . PURPOSE : This randomized phase II trial study genistein see well work treat patient pancreatic cancer remove surgery .</brief_summary>
	<brief_title>Genistein Treating Patients With Pancreatic Cancer That Can Be Removed Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine change microvessel density tumor specimen 2 week treatment genistein patient resectable pancreatic adenocarcinoma . Secondary - To evaluate safety tolerability genistein patient look impact genistein pancreatic cancer angiogenesis angiogenic factor VEGF , CXCL1 , CXCL5 , CXCL8 . OUTLINE : Patients randomize 1 2 treatment arm . - Arm I : Patients receive neoadjuvant oral genistein daily 2 week absence disease progression unacceptable toxicity . - Arm II : Patients receive specific neoadjuvant therapy . In arm , patient undergo surgical resection week 3 . Blood , urine , tissue sample collect baseline time surgery laboratory biomarker study . Samples analyze VEGF , CXCL1 , CXCL5 , CXCL8 ELISA genistein mass spectrometry .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<criteria>Adults age 18 capable give informed consent resectable pancreatic mass , know presumed primary pancreatic adenocarcinoma . Patients whose initial biopsy show adenocarcinoma receive study drug . ECOG preformance status 02 . Negative pregnancy test prior initiation treatment adequate contraception throughout treatment . Exclusion criterion : comorbid disease medical condition would impair ability patient receive comply study protocol hypersensitivity genistein excipients genistein prior chemotherapy radiotherapy pancreatic adenocarcinoma concomitant use warfarin , tamoxifen , raloxifene . pregnancy inadequate contraception . lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
</DOC>